Revenue
0 USD
2023 Q2 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Market value is not computed: no recent price is available.
15 filing records in this dataset, filed from 2019-10-09 to 2023-04-13. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 2004-06-14 to 2026-11-18; this is not a statement that none were filed.
0 USD
3895000 shares
0.00% · 0 shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
0 USD
2022-03-01 – 2023-02-28
-28.9 thousand USD
2022-03-01 – 2023-02-28
-23.5 thousand USD
2022-03-01 – 2023-02-28
0 USD
2020-09-01 – 2021-08-31
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2023-04-13.
Financial data available through: 2022-08-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 4,000
–
Current period
USD 0
–
0 − 4000 = -4000 USD
4000 USD · 2020-09-01 – 2021-08-31
Inspect prior input Prior source0 USD · 2021-09-01 – 2022-08-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 29,503
–
Current period
−USD 14,112
–
-14112 − -29503 = 15391 USD
-29503 USD · 2020-09-01 – 2021-08-31
Inspect prior input Prior source-14112 USD · 2021-09-01 – 2022-08-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 26,265
–
Current period
−USD 14,210
–
-14210 − -26265 = 12055 USD
-26265 USD · 2020-09-01 – 2021-08-31
Inspect prior input Prior source-14210 USD · 2021-09-01 – 2022-08-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2019 2018-09-20 – 2019-08-31 | 0 | Unavailable | Unavailable | Unavailable | -978 | -978 Derived | Source
|
| 2020 2019-09-01 – 2020-08-31 | 4000 | -2310 Derived | 6310 | 11642 Derived | -5332 | -9035 Derived | Source
|
| 2021 2020-09-01 – 2021-08-31 | 4000 | -25503 Derived | 29503 | 59006 Derived | -29503 | -26265 Derived | Source
|
| 2022 2021-09-01 – 2022-08-31 | 0 | -14112 Derived | 14112 | 28224 Derived | -14112 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Revenue | 0 |
|
| 2020 | Revenue | 4000 |
|
| 2021 | Revenue | 4000 |
|
| 2022 | Revenue | 0 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Year over year | No prior comparable period |
|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | 0% |
|
| 2022 | Year over year | -100% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019-08-31 | Operating margin | Not reported |
|
| 2020 | Operating margin | 157.8% |
|
| 2021 | Operating margin | 737.6% |
|
| 2022 | Operating margin | Not reported |
|
| 2019-08-31 | Net margin | Not reported |
|
| 2020 | Net margin | -133.3% |
|
| 2021 | Net margin | -737.6% |
|
| 2022 | Net margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | -225.9% |
|
| 2021 | Free cash flow margin | -656.6% |
|
| 2022 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Operating cash flow | -978 |
|
| 2020 | Operating cash flow | -3896 |
|
| 2021 | Operating cash flow | -26265 |
|
| 2022 | Operating cash flow | -14210 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2019 | Free cash flow | -978 |
|
| 2020 | Free cash flow | -9035 |
|
| 2021 | Free cash flow | -26265 |
|
| 2022 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Liabilities / assets | 59.6% |
|
| 2020 | Liabilities / assets | 24.9% |
|
| 2021 | Liabilities / assets | 183.3% |
|
| 2022 | Liabilities / assets | Not reported |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2019 | Current assets / current liabilities | 1.68× |
|
| 2020 | Current assets / current liabilities | 3.54× |
|
| 2021 | Current assets / current liabilities | 0.39× |
|
| 2022 | Current assets / current liabilities | Not reported |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2019 2018-09-20 – 2019-08-31 | −USD 978 Exact valueExact value: -978 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 978 Exact valueExact value: -978 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 978 Calculation and evidence-978 − 0 USD Exact free cash flow: -978 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2019 2018-09-21 – 2019-08-31 | −USD 978 Exact valueExact value: -978 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2020 2019-09-01 – 2020-08-31 | −USD 5,332 Exact valueExact value: -5332 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3,896 Exact valueExact value: -3896 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 5,139 Exact valueExact value: 5139 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9,035 Calculation and evidence-3896 − 5139 USD Exact free cash flow: -9035 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2020-09-01 – 2021-08-31 | −USD 29,503 Exact valueExact value: -29503 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 26,265 Exact valueExact value: -26265 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 26,265 Calculation and evidence-26265 − 0 USD Exact free cash flow: -26265 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2021-09-01 – 2022-08-31 | −USD 14,112 Exact valueExact value: -14112 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 14,210 Exact valueExact value: -14210 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
15 filings · 644 latest values · 644 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001787123, 1787123, LQLY, edgar:1787123
Also known as AZAR INTERNATIONAL CORP., Azar International Corp., QLY BIOTECH GROUP CORP., QLY Biotech Group Corp.